News
Home>News & Events>Publications>An Evidence-Based Drug Development Tool for Tuberculosis Regimens: The Hollow Fiber System Model
Related Posts
-
Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis
-
Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
-
Mycobacterial biomaterials and resources for researchers
-
CPTR Newsletter – April 2018
-
Global Health Partners Accelerate Uptake of Genetic Sequencing for Surveillance And Diagnosis Of Drug-Resistant Tuberculosis